65 results
Page 2 of 4
8-K
vtp y4vsae
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm
8-K
EX-99.1
4orfjq7vvml8pcxe
5 May 22
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
4:04pm
8-K
EX-99.1
d8zroxa 84
20 Apr 22
Windtree Announces Positive Topline Results from Its
7:07am
8-K
EX-99.1
nbx 0k2y6be9izojdz0
15 Mar 22
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock
7:04am
8-K
EX-99.1
adba3wjwqrlpsf
14 Aug 19
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
12:00am
8-K
EX-99.1
vikup5v
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
8-K
kgs1qz fn27ymfo
29 Jul 11
Other Events
12:00am